Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease

被引:83
作者
Centis, Elena [1 ]
Moscatiello, Simona [1 ]
Bugianesi, Elisabetta [2 ]
Bellentani, Stefano [3 ]
Fracanzani, Anna Ludovica [4 ]
Calugi, Simona [5 ]
Petta, Salvatore [6 ]
Dalle Grave, Riccardo [5 ]
Marchesini, Giulio [1 ]
机构
[1] Alma Mater Studiorum Univ, Unit Metab Dis & Clin Dietet, Bologna, Italy
[2] Univ Turin, Gastroenterol Unit, I-10124 Turin, Italy
[3] Ramazzini Hosp, Carpi, MO, Italy
[4] IRCCS Ca Granda Fdn, Maggiore Hosp, Univ Dept Internal Med, Milan, Italy
[5] Villa Garda Hosp, Unit Eating & Weight Disorders, Garda, VR, Italy
[6] Univ Palermo, Gastroenterol Sect, DiBiMIS, I-90133 Palermo, Italy
关键词
Lifestyle; Psychological factors; Physical activity; Healthy diet; TRANSTHEORETICAL MODEL; SELF-EFFICACY; PHYSICAL-ACTIVITY; BEHAVIOR; STEATOHEPATITIS; POPULATION; VALIDATION; INTERVENTION; THERAPY; NAFLD;
D O I
10.1016/j.jhep.2012.11.031
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Backgrounds 82 Aims: Healthy diet and physical activity are the treatment cornerstones of non-alcoholic fatty liver disease (NAFLD); their effectiveness is however limited by difficulties in implementing lifestyle changes. We aimed at determining the stage of change and associated psychological factors as a prerequisite to refine strategies to implement behavior changes. Methods: We studied 138 consecutive NAFLD patients (73% male, age 19-73 years). The diagnosis was confirmed by liver biopsy in 64 cases (steatohepatitis, 47%). All cases completed the validated EMME-3 questionnaire, consisting of two parallel sets of instruments (for diet and physical activity, respectively) and providing stages of change according to transtheoretical model. Logistic regression analysis was used to identify factors associated with stages making behavioral changes more demanding. Results: The individual profiles were variable; for diet, no cases had precontemplation as prevalent stage of change (highest score in individual profiles); 36% had contemplation. For physical activity, 50% were classified in either precontemplation or contemplation. Minor differences were recorded in relation to associated metabolic complications or steatohepatitis. Logistic regression identified male sex (odds ratio, 4.51; 95% confidence interval, 1.69-12.08) and age (1.70; 1.20-2.43 per decade) as the independent parameters predicting precontemplation or contemplation for diet. No predictors were identified for physical activity. Conclusions: NAFLD cases have scarce readiness to lifestyle changes, particularly with regard to physical activity. Defining stages of change and motivation offers the opportunity to improve clinical care of NAFLD people through individual programs exploiting the powerful potential of behavioral counseling, an issue to be tested in longitudinal studies. (C) 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:771 / 777
页数:7
相关论文
共 54 条
[1]
Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities? [J].
Ahmed, Mohamed H. ;
Abu, Emmanuel O. ;
Byrne, Christopher D. .
PRIMARY CARE DIABETES, 2010, 4 (03) :129-137
[2]
Ajzen I., 1985, INTENTIONS ACTIONS T, DOI DOI 10.1007/978-3-642-69746-32
[3]
[Anonymous], 2002, HLTH BEHAV HLTH ED T
[4]
[Anonymous], 2006, DIS MANAGE, DOI DOI 10.1089/DIS.2006.9.102
[5]
[Anonymous], 1957, Selective Exposure Theory
[6]
SELF-EFFICACY - TOWARD A UNIFYING THEORY OF BEHAVIORAL CHANGE [J].
BANDURA, A .
PSYCHOLOGICAL REVIEW, 1977, 84 (02) :191-215
[7]
Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach [J].
Bellentani, Stefano ;
Dalle Grave, Riccardo ;
Suppini, Alessandro ;
Marchesini, Giuho .
HEPATOLOGY, 2008, 47 (02) :746-754
[8]
Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma [J].
Bugianesi, E ;
Leone, N ;
Vanni, E ;
Marchesini, G ;
Brunello, F ;
Carucci, P ;
Musso, A ;
De Paolis, P ;
Capussotti, L ;
Salizzoni, M ;
Rizzetto, M .
GASTROENTEROLOGY, 2002, 123 (01) :134-140
[9]
Centis E, 2013, CURR PHARM DES
[10]
Centis E, 2012, DIABETE, V24, P26